本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Avidity Biosciences, Inc.

26.57
-1.5300-5.44%
盘后26.570.00000.00%19:18 EDT
成交量:184.12万
成交额:4,936.40万
市值:31.94亿
市盈率:-9.20
高:27.83
开:26.93
低:26.23
收:28.10
数据加载中...
2024/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/12

重要事件披露

Form 8-K - Current report
2024/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/06

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/04

重要事件披露

Form 8-K - Current report
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

重要事件披露

Form 8-K - Current report